Gene editing transforms life of teen with thalassemia

A 16-year-old with thalassemia, previously dependent on monthly blood transfusions, has had her life transformed by gene editing. The treatment appears to have eliminated her need for transfusions, though long-term durability and broader applicability remain unconfirmed. This marks a notable advance in gene therapy for a common inherited blood disorder.